Symbollon Pharma Revenue, Profits - SYMBA Annual Income Statement

Add to My Stocks
$0 $0 (0%) SYMBA stock closing price Aug 25, 2014 (Closing)

Fundamental analysis of SYMBA stock involves analyzing its financial statements, apart from checking the Symbollon Pharma stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the SYMBA stock. The operating expenses as shown in the Symbollon Pharma profit and loss statement for 2010 total to $0. This line item shows that the operating expenses has decreased compared with last year. Also check: Symbollon Pharma assets and Symbollon Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec201020092008
Symbollon Pharma Revenues or Net Sales
---
Cost Of Goods Sold (COGS)---
Symbollon Pharma Gross Profit
---
Research & Development Expense---
Selling General & Admin Expense--1.2M
Income Before Depreciation Depletion Amortization-0.42M-0.69M-1.79M
Depreciation Depletion Amortization---
Non Operating Income-0.02M--
Interest Expense---
Symbollon Pharma Pretax Income
-0.44M-0.69M-1.78M
Provision for Income Taxes---
MinorityInterest---
Investment Gains Losses---
Other Income---
Income Before Extraordinaries & Disc Operations-0.44M-0.69M-1.78M
Extraordinary Items & Discontinued Operations---
Symbollon Pharma Profit/ Loss (Net Income)
-0.44M-0.69M-1.78M
Average Shares used to compute Diluted EPS35.67M22.11M-
Average Shares used to compute Basic EPS35.67M22.11M-
Income Before Nonrecurring Items-0.45M-0.69M-
Income from Nonrecurring Items---
Symbollon Pharma Earnings Per Share Basic Net
-0.01-0.03-0.11
Symbollon Pharma Earnings Per Share Diluted Net
-0.01-0.03-
EPS Diluted Before Nonrecurring Items-0.01-0.03-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common0.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Symbollon Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2010. Our Symbollon Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-0.44M for Symbollon Pharma for 2010. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The SYMBA financials along with Symbollon Pharma historical stock prices provide a lot of details about the firm.

Annual Income Statements - Symbollon Pharmaceuticals, Inc. Industry Peers

Applied Neurosolutions income statement, Taxus Cardium Pharma income statement, Hemispherx BioPharma income statement